Industry › BioTech
Press Releases
SinoMab Announces Clinical Results on its First-in-target SM03 at EULAR 2020 Congress
SinoMab BioScience Limited
Jun 10, 2020 07:52 HKT/SGT
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
Avance Clinical
Jun 09, 2020 21:00 JST
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
Avance Clinical
Jun 09, 2020 20:00 HKT/SGT
Jones Day Advises GenScript Biotech Corporation on $423.8 million Initial Public Offering and Spin-off of Subsidiary Legend Biotech Corporation
Jones Day
Jun 09, 2020 13:53 HKT/SGT
Joonghun Pharmaceutical of Korea Targets Overseas Markets for Coronavirus Diagnostic Kits
Joonghun Pharmaceutical Co., Ltd.
Jun 09, 2020 11:00 HKT/SGT
Eisai: Brain Performance (Brain-Health) Self-Check Tool "NouKNOW" to be Used in Beauty Salons
Eisai
Jun 04, 2020 10:43 HKT/SGT
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Alset International Ltd
Jun 02, 2020 16:30 HKT/SGT
Blockchain Holdings Ltd. subsidiary TraceSafe and Toronto Wolfpack Sign Contract for Wearable Technology to Safely Reopen Lamport Stadium
TraceSafe Inc.
Jun 02, 2020 00:00 HKT/SGT
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Alset International Ltd
Jun 01, 2020 13:00 HKT/SGT
Novotech 與 Endpoints News 合作舉辦有關亞太地區臨床試驗前景的系列網絡研討會
Novotech Health Holdings Pte Ltd
Jun 01, 2020 09:00 HKT/SGT
Novotech 与 Endpoints News 合作举办有关亚太地区临床试验前景的系列网络研讨会
Novotech Health Holdings Pte Ltd
Jun 01, 2020 09:00 HKT/SGT
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
Digital Diagnostics AG
May 30, 2020 11:00 JST
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
Digital Diagnostics AG
May 30, 2020 10:00 HKT/SGT
アッヴィとエーザイ、ヒト型抗ヒトTNFαモノクローナル抗体「ヒュミラ(R)」について、化膿性汗腺炎の効能・効果に係る用法・用量の製造販売承認事項一部変更の承認取得のお知らせ
Eisai
May 29, 2020 15:00 JST
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials
Eisai
May 29, 2020 10:31 HKT/SGT